Education
About Us
Working with TipRanks
Follow Us
SAWS - AI Analysis
Top Page
AAM Sawgrass US Small Cap Quality Growth ETF (SAWS)
Rating:72Outperform
Price Target:
$23.50
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as StoneX Group and Artivion, have delivered strong year-to-date performance, supporting overall fund growth.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Industrials, Technology, and Health Care, reducing reliance on any single industry.
Quality Growth Focus
The fund targets small-cap companies with strong growth potential, which can offer higher returns compared to larger, more established firms.
Negative Factors
High Geographic Concentration
The ETF is heavily concentrated in U.S. companies, offering limited exposure to international markets and global diversification.
Mixed Recent Performance
While the fund has shown strong three-month gains, its one-month performance has been slightly negative, indicating short-term volatility.
Above-Average Expense Ratio
The ETF's expense ratio of 0.55% is higher than some low-cost alternatives, which could reduce net returns over time.
SAWS vs. SPDR S&P 500 ETF (SPY)
AUM1.47M
RegionNorth America
Expense Ratio0.55%
Beta0.98
IssuerAAM
Inception DateJul 30, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume755
30 Day Avg. Volume373
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
24.04Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering71
SAWS Summary
The AAM Sawgrass US Small Cap Quality Growth ETF (Ticker: SAWS) focuses on small U.S. companies with strong financial health and growth potential. These companies typically have market values between $300 million and $2 billion and are known for their innovation and agility. The ETF includes businesses like StoneX Group and Artivion, and it invests in sectors such as technology, healthcare, and industrials. Investors might consider SAWS for its potential to deliver growth and diversify their portfolios by tapping into emerging market leaders. However, since it focuses on smaller companies, the ETF can be more volatile and sensitive to market changes than funds with larger, more established firms.
How much will it cost me?The AAM Sawgrass US Small Cap Quality Growth ETF (Ticker: SAWS) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting high-quality small-cap growth stocks rather than tracking a broad index.
What would affect this ETF?The SAWS ETF, focused on U.S. small-cap growth companies, could benefit from a strong U.S. economy, technological innovation, and increased demand for healthcare and industrial solutions, given its sector exposure. However, it may face challenges from rising interest rates, which can make borrowing more expensive for small companies, and economic slowdowns that could disproportionately impact smaller firms. Regulatory changes or sector-specific disruptions in industries like technology or healthcare could also influence its performance.
SAWS Top 10 Holdings
The AAM Sawgrass US Small Cap Quality Growth ETF is leaning heavily on industrials, technology, and healthcare, which together make up a significant portion of its portfolio. InterDigital is a standout performer, riding high on strong profitability and strategic agreements, while Phibro Animal Health is also making waves with robust earnings growth despite valuation concerns. On the flip side, CommVault Systems is lagging, weighed down by short-term bearish momentum and acquisition-related risks. With its focus on U.S. small-cap stocks, this fund is tapping into the innovation and agility of emerging market leaders, though some names are struggling to keep pace.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Artivion | 4.14% | $60.96K | $2.15B | 73.38% | 53 Neutral | |
| StoneX Group | 3.91% | $57.60K | $4.59B | 55.65% | 58 Neutral | |
| Iradimed | 2.91% | $42.84K | $972.06M | 55.10% | 81 Outperform | |
| InterDigital | 2.81% | $41.35K | $10.23B | 163.47% | 79 Outperform | |
| Huron Consulting | 2.71% | $39.86K | $2.85B | 42.92% | 73 Outperform | |
| Phibro Animal Health | 2.46% | $36.21K | $1.70B | 81.06% | 71 Outperform | |
| Red Violet | 2.38% | $34.99K | $716.50M | 70.41% | 76 Outperform | |
| Sanmina-Sci | 2.34% | $34.52K | $7.22B | 93.27% | 79 Outperform | |
| Archrock | 2.34% | $34.44K | $4.46B | 26.92% | 78 Outperform | |
| Pricesmart | 2.25% | $33.18K | $3.78B | 47.94% | 78 Outperform |
SAWS Technical Analysis
Neutral
―
Price Trends
20.98
Negative
20.31
Positive
19.77
Positive
Market Momentum
0.07
Negative
48.26
Neutral
32.04
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SAWS, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 20.96, equal to the 50-day MA of 20.98, and equal to the 200-day MA of 19.77, indicating a neutral trend. The MACD of 0.07 indicates Negative momentum. The RSI at 48.26 is Neutral, neither overbought nor oversold. The STOCH value of 32.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SAWS.
SAWS Peer Comparison
Comparison Results
Performance Comparison
SAWS
AAM Sawgrass US Small Cap Quality Growth ETF
20.92
1.78
9.30%
TMFS
Motley Fool Small-Cap Growth ETF
―
―
―
OASC
OneAscent Small Cap Core ETF
―
―
―
FSCC
Federated Hermes MDT Small Cap Core ETF
―
―
―
AFSM
First Trust Active Factor Small Cap ETF
―
―
―
MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents